Developmental motoneuron cell death and neurotrophic factors

被引:117
作者
Sendtner, M [1 ]
Pei, G [1 ]
Beck, M [1 ]
Schweizer, U [1 ]
Wiese, S [1 ]
机构
[1] Univ Wurzburg, Neurol Klin, Klin Forsch Grp Neuroregenerat, D-97080 Wurzburg, Germany
关键词
motoneuron cell death; neurotrophic factors; lumbar spinal cord; rat;
D O I
10.1007/s004410000217
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
During the development of higher vertebrates, motoneurons are generated in excess. In the lumbar spinal cord of the developing rat, about 6000 motoneurons are present at embryonic day 14. These neurons grow out axons which make contact with their target tissue, the skeletal muscle, and about 50% of the motoneurons are lost during a critical period from embryonic day 14 until postnatal day 3. This process, which is called physiological motoneuron cell death, has been the focus of research aiming to identify neurotrophic factors which regulate motoneuron survival during this developmental period. Motoneuron cell death can also be observed in vitro when the motoneurons are isolated from the embryonic avian or rodent spinal cord. These isolated motoneurons and other types of primary neurons have been a useful tool for studying basic mechanisms underlying neuronal degeneration during development and under pathophysiological conditions in neurodegenerative disorders. Accumulating evidence from such studies suggests that some specific requirements of motoneurons for survival and proper function may change during development. The focus of this review is a synopsis of recent data on such specific mechanisms.
引用
收藏
页码:71 / 84
页数:14
相关论文
共 131 条
[1]   DIFFERENTIAL EFFECT OF NGF AND EGF ON ERK IN NEURONALLY DIFFERENTIATED PC12 CELLS [J].
ALETTA, JM .
NEUROREPORT, 1994, 5 (16) :2090-2092
[2]   Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis [J].
Aoki, M ;
Lin, CLG ;
Rothstein, JD ;
Geller, BA ;
Hosler, BA ;
Munsat, TL ;
Horvitz, HR ;
Brown, RH .
ANNALS OF NEUROLOGY, 1998, 43 (05) :645-653
[3]  
ARAKAWA Y, 1990, J NEUROSCI, V10, P3507
[4]   TrnR2, a novel receptor that mediates neurturin and GDNF signaling through Ret [J].
Baloh, RH ;
Tansey, MG ;
Golden, JP ;
Creedon, DJ ;
Heuckeroth, RO ;
Keck, CL ;
Zimonjic, DB ;
Popescu, NC ;
Johnson, EM ;
Milbrandt, J .
NEURON, 1997, 18 (05) :793-802
[5]   Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRα3-RET receptor complex [J].
Baloh, RH ;
Tansey, MG ;
Lampe, PA ;
Fahrner, TJ ;
Enomoto, H ;
Simburger, KS ;
Leitner, ML ;
Araki, T ;
Johnson, EM ;
Milbrandt, J .
NEURON, 1998, 21 (06) :1291-1302
[6]   The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death [J].
Bamji, SX ;
Majdan, M ;
Pozniak, CD ;
Belliveau, DJ ;
Aloyz, R ;
Kohn, J ;
Causing, CG ;
Miller, FD .
JOURNAL OF CELL BIOLOGY, 1998, 140 (04) :911-923
[7]  
BARDE Y-A, 1990, Progress in Growth Factor Research, V2, P237, DOI 10.1016/0955-2235(90)90021-B
[8]   MICROINJECTION OF THE RAS ONCOGENE PROTEIN INTO PC12 CELLS INDUCES MORPHOLOGICAL-DIFFERENTIATION [J].
BARSAGI, D ;
FERAMISCO, JR .
CELL, 1985, 42 (03) :841-848
[9]   PHOSPHOTYROSINE RESIDUES IN THE NERVE-GROWTH-FACTOR RECEPTOR (TRK-A) - THEIR ROLE IN THE ACTIVATION OF INOSITOLPHOSPHOLIPID METABOLISM AND PROTEIN-KINASE CASCADES IN PHEOCHROMOCYTOMA (PC12) CELLS [J].
BAXTER, RM ;
COHEN, P ;
OBERMEIER, A ;
ULLRICH, A ;
DOWNES, CP ;
DOZA, YN .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 234 (01) :84-91
[10]   A CONTROLLED TRIAL OF RILUZOLE IN AMYOTROPHIC-LATERAL-SCLEROSIS [J].
BENSIMON, G ;
LACOMBLEZ, L ;
MEININGER, V ;
BOUCHE, P ;
DELWAIDE, C ;
COURATIER, P ;
BLIN, O ;
VIADER, F ;
PEYROSTPAUL, H ;
DAVID, J ;
MALOTEAUX, JM ;
HUGON, J ;
LATERRE, EC ;
RASCOL, A ;
CLANET, M ;
VALLAT, JM ;
DUMAS, A ;
SERRATRICE, G ;
LECHEVALLIER, B ;
PEUCH, AJ ;
NGUYEN, T ;
SHU, C ;
BASTIEN, P ;
PAPILLON, C ;
DURRLEMAN, S ;
LOUVEL, E ;
GUILLET, P ;
LEDOUX, L ;
ORVOENFRIJA, E ;
DIB, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (09) :585-591